BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33204001)

  • 1. Long non-coding RNA FOXD3-AS1 silencing exerts tumor suppressive effects in nasopharyngeal carcinoma by downregulating FOXD3 expression via microRNA-185-3p upregulation.
    Hu J; Pan J; Luo Z; Duan Q; Wang D
    Cancer Gene Ther; 2021 Jun; 28(6):602-618. PubMed ID: 33204001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA PTPRG-AS1 acts as a microRNA-194-3p sponge to regulate radiosensitivity and metastasis of nasopharyngeal carcinoma cells via PRC1.
    Yi L; Ouyang L; Wang S; Li SS; Yang XM
    J Cell Physiol; 2019 Aug; 234(10):19088-19102. PubMed ID: 30993702
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Wan N; Yang W; Cheng H; Wang J
    Cancer Biother Radiopharm; 2020 Oct; 35(8):596-604. PubMed ID: 32354225
    [No Abstract]   [Full Text] [Related]  

  • 4. LncRNA FOXD3-AS1 promotes breast cancer progression by mediating ARF6.
    Zhang X; Zhao X; Chang L; Liu F; Li C; Ge P
    Breast Cancer; 2022 Sep; 29(5):908-920. PubMed ID: 35678943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly expressed lncRNA FOXD3-AS1 promotes non-small cell lung cancer progression via regulating miR-127-3p/mediator complex subunit 28 axis.
    Zeng ZL; Zhu HK; He LF; Xu X; Xie A; Zheng EK; Ni JJ; Liu JT; Zhao GF
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2525-2538. PubMed ID: 32196603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA PTPRG-AS1/microRNA-124-3p regulates radiosensitivity of nasopharyngeal carcinoma via the LIM Homeobox 2-dependent Notch pathway through competitive endogenous RNA mechanism.
    Shen Z; Wu Y; He G
    Bioengineered; 2022 Apr; 13(4):8208-8225. PubMed ID: 35300558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
    Chen Y; Gao H; Li Y
    Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
    Shi J; Tan S; Song L; Song L; Wang Y
    Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2.
    Chen X; Gao J; Yu Y; Zhao Z; Pan Y
    Biomed Pharmacother; 2019 Dec; 120():109438. PubMed ID: 31541886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA FOXD3-AS1 regulates oxidative stress-induced apoptosis
    Zhang D; Lee H; Haspel JA; Jin Y
    FASEB J; 2017 Oct; 31(10):4472-4481. PubMed ID: 28655711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA FOXD3-AS1 promotes colon adenocarcinoma progression and functions as a competing endogenous RNA to regulate SIRT1 by sponging miR-135a-5p.
    Wu Q; Shi M; Meng W; Wang Y; Hui P; Ma J
    J Cell Physiol; 2019 Dec; 234(12):21889-21902. PubMed ID: 31058315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA LUADT1 promotes nasopharyngeal carcinoma cell proliferation and invasion by downregulating miR-1207-5p.
    Jiang N; Zhao L; Zong D; Yin L; Wu L; Chen C; Song X; Zhang Q; Jiang X; He X; Feng J
    Bioengineered; 2021 Dec; 12(2):10716-10728. PubMed ID: 34738862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA MSC-AS1/miRNA-429 Axis Mediates Growth and Metastasis of Nasopharyngeal Carcinoma via JAK1/STAT3 Signaling Pathway.
    Luo N
    Comput Math Methods Med; 2022; 2022():1447207. PubMed ID: 36213586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulated long non-coding RNA LHFPL3 antisense RNA 1 inhibits the radiotherapy resistance of nasopharyngeal carcinoma via modulating microRNA-143-5p/homeobox A6 axis.
    Wang W; Zhang Z; Li Y; Gu A; Wang Y; Cai Y; Yu Y; Deng X
    Bioengineered; 2022 Mar; 13(3):5421-5433. PubMed ID: 35176945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA FOXD3-AS1 Contributes to Glioblastoma Progression Via Sponging miR-3918 to Upregulate CCND1.
    Huang C; Shao T; Duan F; Li R; Luo M; Huang Q; Wang Y; Luo Z
    Turk Neurosurg; 2024; 34(2):224-234. PubMed ID: 38497174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression.
    Huang H; Yang C; Zhang Q; Zhuo T; Li X; Li N; Zhu L; Luo C; Gan J; Wu Y
    Bioengineered; 2022 Mar; 13(3):4964-4977. PubMed ID: 35164653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p.
    Kong S; Xue H; Li Y; Li P; Ma F; Liu M; Li W
    Exp Cell Res; 2020 Oct; 395(1):112180. PubMed ID: 32682012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long non-coding RNA MACC1-AS1 promotes nasopharyngeal carcinoma cell stemness via suppressing miR-145-mediated inhibition on SMAD2/MACC1-AS1 axis.
    Chen S; Luo X; Wu W; Li Y; Yu H; Wang Y; Yan J
    Biomed Pharmacother; 2020 May; 125():109986. PubMed ID: 32058221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SP1-induced lncRNA FOXD3-AS1 contributes to tumorigenesis of cervical cancer by modulating the miR-296-5p/HMGA1 pathway.
    Ma WG; Shi SM; Chen L; Lou G; Feng XL
    J Cell Biochem; 2021 Feb; 122(2):235-248. PubMed ID: 32959937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA AFAP1-AS1 acts as a competing endogenous RNA of miR-423-5p to facilitate nasopharyngeal carcinoma metastasis through regulating the Rho/Rac pathway.
    Lian Y; Xiong F; Yang L; Bo H; Gong Z; Wang Y; Wei F; Tang Y; Li X; Liao Q; Wang H; Zhou M; Xiang B; Wu X; Li Y; Li X; Chen X; Li G; Guo C; Zeng Z; Xiong W
    J Exp Clin Cancer Res; 2018 Oct; 37(1):253. PubMed ID: 30326930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.